These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39141311)

  • 1. Lipoprotein glomerulopathy with a novel apolipoprotein E variant, APOE Kanto (Asp 151dup).
    Yokochi A; Matsunaga A; Kanemoto K; Tominaga N; Uda S; Saito T
    CEN Case Rep; 2024 Aug; ():. PubMed ID: 39141311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
    da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
    Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report.
    Kato J; Okonogi H; Kanzaki G; Katsumata H; Nakada Y; Sagasaki M; Komine K; Ito K; Saito T; Matsunaga A; Tokutou K; Honda K; Tsuboi N; Yokoo T
    BMC Nephrol; 2024 May; 25(1):171. PubMed ID: 38769490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate.
    Kodera H; Mizutani Y; Sugiyama S; Miyata T; Ehara T; Matsunaga A; Saito T
    Case Rep Nephrol Dial; 2017; 7(2):112-120. PubMed ID: 28966924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
    Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
    Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.
    Wang R; Zhao C; Chen W; Liu Z; Xie F
    J Med Case Rep; 2022 Feb; 16(1):78. PubMed ID: 35193676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
    Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T
    J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein Glomerulopathy, First Case Report from Canada.
    Ting JA; McRae SA; Schwartz D; Barbour SJ; Riazy M
    Int J Nephrol Renovasc Dis; 2022; 15():207-214. PubMed ID: 35761986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
    Wu H; Yang Y; Hu Z
    J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report.
    Li Y; Chen J; Zou Y; Wang W; Li G
    Medicine (Baltimore); 2022 Feb; 101(5):e28718. PubMed ID: 35119017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.
    Qin Y; Sun XJ; Hu YF; Jing M; Yu XJ; Zhao MH; Tan Y
    Ren Fail; 2024 Dec; 46(1):2332491. PubMed ID: 38584145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes.
    Kato T; Ushiogi Y; Yokoyama H; Hara S; Matsunaga A; Muso E; Saito T
    CEN Case Rep; 2019 May; 8(2):106-111. PubMed ID: 30701487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E-related glomerular disorders.
    Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
    Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
    Xie W; Xie Y; Lin Z; Xu X; Zhang Y
    Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
    Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
    Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
    Arai T; Yamashita S; Yamane M; Manabe N; Matsuzaki T; Kiriyama K; Kanayama Y; Himeno S; Matsuzawa Y
    Atherosclerosis; 2003 Aug; 169(2):293-9. PubMed ID: 12921981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation.
    Hu Z; Huang S; Wu Y; Liu Y; Liu X; Su D; Tao Y; Fu P; Zhang X; Peng Z; Zhang S; Yang Y
    Kidney Int; 2014 Feb; 85(2):416-24. PubMed ID: 24025644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy.
    Lui DTW; Lee ACH; Yap DYH; Chan GSW; Tan KCB
    J Clin Lipidol; 2019; 13(2):251-253. PubMed ID: 30685233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy.
    Takasaki S; Maeda K; Joh K; Yamakage S; Fukase S; Takahashi T; Suzuki M; Matsunaga A; Saito T
    Case Rep Nephrol Dial; 2015; 5(3):204-12. PubMed ID: 26955632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.